Medication management in the context of mental illness: an exploratory study of young people living in Australia

[1]  S. McMillan,et al.  A qualitative study exploring opportunities for pharmacists to connect with young mental health consumers. , 2020, Journal of the American Pharmacists Association : JAPhA.

[2]  S. McMillan,et al.  Young people's experiences with mental health medication: A narrative review of the qualitative literature , 2020, Journal of mental health.

[3]  I. Manion,et al.  Understanding the mental health and recovery needs of Canadian youth with mental health disorders: a Strategy for Patient-Oriented Research (SPOR) collaboration protocol , 2019, International Journal of Mental Health Systems.

[4]  Amy Werremeyer,et al.  Using Photovoice to Document Living With Mental Illness on a College Campus , 2019, Clinical Medicine Insights: Psychiatry.

[5]  N. Rüsch,et al.  Secrecy versus disclosure of mental illness among adolescents: I. The perspective of adolescents with mental illness , 2018, Journal of mental health.

[6]  C. Lochner,et al.  Living with obsessive-compulsive disorder (OCD): a South African narrative , 2018, International Journal of Mental Health Systems.

[7]  N. Midgley,et al.  Meaning and medication: a thematic analysis of depressed adolescents’ views and experiences of SSRI antidepressants alongside psychological therapies , 2018, BMC Psychiatry.

[8]  P. Aslani,et al.  Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study , 2018, Patient preference and adherence.

[9]  Amy Werremeyer,et al.  Self-stigma of antidepressant users through secondary analysis of PhotoVoice data , 2018, The mental health clinician.

[10]  T. Usherwood,et al.  How Marginalized Young People Access, Engage With, and Navigate Health-Care Systems in the Digital Age: Systematic Review. , 2018, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[11]  S. Hall,et al.  Youth survey report 2017 , 2017 .

[12]  A. Moser,et al.  Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis , 2017, The European journal of general practice.

[13]  A. Moser,et al.  Series: Practical guidance to qualitative research. Part 1: Introduction , 2017, The European journal of general practice.

[14]  D. Mazza,et al.  Trends in GP prescribing of psychotropic medications among young patients aged 16–24 years: a case study analysis , 2017, BMC Psychiatry.

[15]  Amy Werremeyer,et al.  Use of Photovoice to Understand the Experience of Taking Psychotropic Medications , 2017, Qualitative health research.

[16]  P. Tennent,et al.  The meanings young people assign to living with mental illness and their experiences in managing their health and lives: a systematic review of qualitative evidence , 2017, JBI database of systematic reviews and implementation reports.

[17]  C. May,et al.  Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden , 2017, Quality of Life Research.

[18]  J. McDonagh,et al.  “Sometimes I feel like a pharmacist”: identity and medication use among adolescents with juvenile arthritis , 2016, Pediatric Rheumatology.

[19]  V. Patel,et al.  Our future: a Lancet commission on adolescent health and wellbeing , 2016, The Lancet.

[20]  M. Chambers,et al.  Service user involvement in mental health care: an evolutionary concept analysis , 2016, Health expectations : an international journal of public participation in health care and health policy.

[21]  K. Deane,et al.  What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis. , 2016, Journal of psychiatric and mental health nursing.

[22]  M. Kyriakopoulos,et al.  The Stigma of Mental Illness in Children & Adolescents: A Systematic Review , 2016 .

[23]  T. Chen,et al.  Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies , 2016, BMJ Open.

[24]  G. Nordström,et al.  Experience of psychotropic drug use among young people with mental health problems , 2015 .

[25]  NHS prescription charges , 2015, Drug and Therapeutics Bulletin.

[26]  Victor M Montori,et al.  Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions , 2015, Patient related outcome measures.

[27]  G. Salum,et al.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[28]  Michelle R. Munson,et al.  Perspectives on Psychotropic Medication Treatment Among Young Adults Formerly Served in Public Systems of Care: A Thematic and Narrative Analysis , 2015, Journal of the Society for Social Work and Research.

[29]  J. Floersch,et al.  ‘I’m loving life’: Adolescents’ empowering experiences of living with a mental illness , 2015 .

[30]  Adem Sav,et al.  Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers. , 2014, Australian health review : a publication of the Australian Hospital Association.

[31]  I. McGregor,et al.  Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty , 2014, The Australian and New Zealand journal of psychiatry.

[32]  Gerard J Fitzsimmons,et al.  From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.

[33]  R. Bluhm,et al.  “I Just Have to Stick with It and It’ll Work”: Experiences of Adolescents and Young Adults with Mental Health Concerns , 2014, Community Mental Health Journal.

[34]  J. McDonagh,et al.  Arthriting: exploring the relationship between identity and medicines use, and to identify the contribution of medicines and pharmacy services, for the care of young people with arthritis , 2013 .

[35]  Jennifer A Whitty,et al.  'You say treatment, I say hard work': treatment burden among people with chronic illness and their carers in Australia. , 2013, Health & social care in the community.

[36]  C. Anderson,et al.  Patient experiences of taking antidepressants for depression: a secondary qualitative analysis. , 2013, Research in social & administrative pharmacy : RSAP.

[37]  Abigail Powell,et al.  Child & Adolescent Mental Health: Are we reaching them yet? Service access patterns among attendees at the headspace youth mental health initiative , 2013 .

[38]  S. Duckett,et al.  Australia's Bad Drug Deal: High Pharmaceutical Prices , 2013 .

[39]  J. Jaccard,et al.  Static, dynamic, integrated, and contextualized: a framework for understanding mental health service utilization among young adults. , 2012, Social science & medicine.

[40]  C. May,et al.  Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study , 2012, Patient related outcome measures.

[41]  A. Sourander,et al.  Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study , 2012, European Journal of Clinical Pharmacology.

[42]  J. Floersch,et al.  What Do African American Youth With a Mental Illness Think About Help-Seeking and Psychiatric Medication?: Origins of Stigmatizing Attitudes , 2012 .

[43]  C. Kieling,et al.  Child and adolescent mental health worldwide: evidence for action , 2011, The Lancet.

[44]  Michelle R. Munson,et al.  A qualitative investigation of self-stigma among adolescents taking psychiatric medication. , 2011, Psychiatric services.

[45]  Charles A. Rapp,et al.  Critical Issues for Psychiatric Medication Shared Decision Making with Youth and Families , 2011 .

[46]  M. Pawsey,et al.  Consensus standards for the care of children and adolescents in Australian health services , 2011, The Medical journal of Australia.

[47]  H. Christensen,et al.  Perceived barriers and facilitators to mental health help-seeking in young people: a systematic review , 2010, BMC psychiatry.

[48]  Jerry Floersch,et al.  Integrating Thematic, Grounded Theory and Narrative Analysis , 2010 .

[49]  P. McGrath,et al.  Adolescents’ Attitudes and Opinions about Depression Treatment , 2010, Community Mental Health Journal.

[50]  Michelle R. Munson,et al.  Stigma experience among adolescents taking psychiatric medication , 2010 .

[51]  Christopher Gillberg,et al.  The Autism - Tics, AD/HD and other Comorbidities inventory (A-TAC): further validation of a telephone interview for epidemiological research , 2010, BMC psychiatry.

[52]  J. Slade.  The Mental health of Australians 2: report on the 2007 national survey of mental health and wellbeing , 2009 .

[53]  S. Francis,et al.  'I'm fine doing it on my own': partnerships between young people and their parents in the management of medication for asthma and diabetes , 2008, Journal of child health care : for professionals working with children in the hospital and community.

[54]  Lisa Gibbs,et al.  Generating best evidence from qualitative research: the role of data analysis , 2007, Australian and New Zealand journal of public health.

[55]  L. S. Haugbølle,et al.  A user perspective on type 1 diabetes: sense of illness, search for freedom and the role of the pharmacy. , 2002, Patient education and counseling.

[56]  S. Kutcher,et al.  A Qualitative Study of Antipsychotic Medication Experiences of Youth. , 2015, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[57]  E. Horsfield.  Exploring the Role of Community Pharmacy in Providing Healthcare to Young People in New Zealand Using a Youth Participation Approach , 2014 .

[58]  Joseph Guada PhD Msw,et al.  What Do African American Youth With a Mental Illness Think About Help-Seeking and Psychiatric Medication?: Origins of Stigmatizing Attitudes , 2012 .